ENDOGENOUS PHARMACOPEIA Trademark

Trademark Overview

On Tuesday, February 14, 2017, a trademark application was filed for ENDOGENOUS PHARMACOPEIA with the United States Patent and Trademark Office. The USPTO has given the ENDOGENOUS PHARMACOPEIA trademark a serial number of 87335380. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Monday, September 9, 2024. The ENDOGENOUS PHARMACOPEIA trademark is filed in the Advertising, Business and Retail Services category with the following description:

Public advocacy to promote awareness of the need for an integrated person centered approach to health care and research
endogenous pharmacopeia

General Information

Serial Number87335380
Word MarkENDOGENOUS PHARMACOPEIA
Filing DateTuesday, February 14, 2017
Status710 - CANCELLED - SECTION 8
Status DateMonday, September 9, 2024
Registration Number5410476
Registration DateTuesday, February 27, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 12, 2017

Trademark Statements

Goods and ServicesPublic advocacy to promote awareness of the need for an integrated person centered approach to health care and research
NOT AVAILABLE"PHARMACOPEIA"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateMonday, September 9, 2024
Primary Code035
First Use Anywhere DateFriday, February 10, 2017
First Use In Commerce DateTuesday, February 14, 2017

Trademark Owner History

Party NameNOT AVAILABLE
Party Type30 - Original Registrant
Legal Entity Type01 - Individual
AddressMcLean, VA 22101
Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressMcLean, VA 22101
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressMcLean, VA 22101

Trademark Events

Event DateEvent Description
Friday, February 17, 2017NEW APPLICATION ENTERED
Wednesday, November 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 12, 2017PUBLISHED FOR OPPOSITION
Tuesday, February 21, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 25, 2017ASSIGNED TO EXAMINER
Friday, April 28, 2017NON-FINAL ACTION WRITTEN
Friday, April 28, 2017NON-FINAL ACTION E-MAILED
Friday, April 28, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 26, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 26, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 26, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 27, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 12, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 27, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, February 14, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, September 1, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, September 1, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 1, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 1, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 1, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 27, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, September 9, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

pharmacopeia endogenous approach centered health care research person integrated advocacy promote awareness